No results for ‘’
Lincoln Pharmaceuticals Ltd
NSE: LINCOLN BSE: 531633
₹615.50
(0.58%)
Thu, 16 Jul 2026, 08:59 am
Market Cap (in Cr)1230.63
PE Ratio14.03
Dividend0.29
Health Technology
Pharmaceuticals: Major
24.5KLincoln Pharmaceuticals Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| NK SECURITIES RESEARCH PRIVATE LIMITED | bulk | Buy | 208466 | 707.51 | 29 Apr 2026 |
| QE SECURITIES LLP | bulk | Buy | 109936 | 701.46 | 29 Apr 2026 |
| NK SECURITIES RESEARCH PRIVATE LIMITED | bulk | Sell | 208466 | 707.93 | 29 Apr 2026 |
| QE SECURITIES LLP | bulk | Sell | 106989 | 709.28 | 29 Apr 2026 |
| GREENX WEALTH MULTIHORIZONS OPPORTUNITY FUND | bulk | Buy | 165255 | 603.07 | 12 Feb 2026 |
| MUSIGMA SECURITIES | bulk | Sell | 160300 | 606.04 | 07 Aug 2025 |
| NK SECURITIES RESEARCH PRIVATE LIMITED | bulk | Sell | 275585 | 600.39 | 07 Aug 2025 |
| IRAGE BROKING SERVICES LLP | bulk | Buy | 92372 | 599.35 | 07 Aug 2025 |
| MUSIGMA SECURITIES | bulk | Buy | 160300 | 604.97 | 07 Aug 2025 |
| IRAGE BROKING SERVICES LLP | bulk | Sell | 104690 | 598.87 | 07 Aug 2025 |
Showing 1–10 of 213
Rows per page: